Fielmann Group AG (FLMNF)
OTCMKTS · Delayed Price · Currency is USD
60.22
0.00 (0.00%)
Dec 12, 2025, 9:30 AM EST
Fielmann Group AG Market Cap
Fielmann Group AG has a market cap or net worth of $4.19 billion as of December 15, 2025. Its market cap has increased by 21.13% in one year.
Market Cap
4.19B
Enterprise Value
4.63B
Revenue
2.84B
Ranking
n/a
PE Ratio
19.59
Stock Price
$60.22
Market Cap Chart
Since March 2, 1998, Fielmann Group AG's market cap has increased from 452.21M to 4.19B, an increase of 827.66%. That is a compound annual growth rate of 8.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 4.19B | 16.30% |
| Dec 30, 2024 | 3.61B | -20.12% |
| Dec 29, 2023 | 4.52B | 35.87% |
| Dec 30, 2022 | 3.32B | -40.90% |
| Dec 30, 2021 | 5.62B | -18.01% |
| Dec 30, 2020 | 6.86B | 1.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.26M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |